The present invention describes the use of
porous metal oxides for the preparative purification of antibodies and biomolecules within a range of particle physical characteristics. Typically, particles from 15 to 100 microns in
average diameter with pores sizes
ranging from 400 to 600 angstroms and surface areas from 10 to 50 square meters per
gram, and pore volumes from 0.1 to 0.4 mL /
gram can be used for purification processes. The
metal oxide particles that fall within this range of physical properties show enhanced utility and greater chromatographic capacity for antibodies than materials
oxide particles falling outside of this range.
Metal oxides such as zirconia, titania and
alumina can all be modified with a multi-Lewis base
moiety such as an
organophosphate ethylenediamine-N,N-
tetra(methylenephosphonic) acid (EDTPA), to produce a bio-compatible purification media for, biomolecules.